Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Discontinued Operations

v2.4.0.8
Note 9 - Discontinued Operations
6 Months Ended
Jun. 30, 2013
Notes  
Note 9 - Discontinued Operations

Note 9 - Discontinued Operations

 

Pursuant to accounting rules for discontinued operations, the Company has classified all gain, revenue and expense related to the operations, assets, and liabilities of its bio-pharmaceutical business as discontinued operations.  For the six-month periods ended June 30, 2013 and 2012, Income from Discontinued Operations consists of the foreign currency transaction gains related to current liabilities associated with the discontinued operations that are denominated in Euros.